Significant positive correlations between CD47 and IFT57 mRNA expression extended to neuroendocrine tumors, sarcomas, and some hematologic malignancies, but IFT57 and CD47 co-expression had lower Spearman’s coefficients and rank orders in these cancers (Table 1). This evidence concerns the gene CD47 and hematologic disorder.